|
Status
|
Topic selection
|
|
Technology type
|
Medicine
|
|
Decision
|
Not selected
|
|
Reason for decision
|
Not eligible for Health Technology Evaluation guidance
|
|
Further information
|
Decision makers have concluded that this technology will not progress as a potential technology appraisal or a highly specialised technology. New generic or biosimilar medicines are not eligible to be considered if the branded version is recommended in NICE technology appraisal or highly specialised technologies guidance. Please see section 4.2.8 of the topic selection manual for further information.
|
| ID number |
11832
|
Project Team
| Project lead |
Abigail Stephens |
Email enquiries
For further information on how we select topics for development, please see our page about topic selection